Fed. Circ. Won't Rethink Axed Stanford Kidney Test Patents

By Lauren Berg (December 2, 2022, 10:21 PM EST) — The Federal Circuit on Friday declined to review en banc a panel’s decision that three Stanford University diagnostic patents licensed to a developer of commercial tests for kidney transplant rejections are ineligible for protection….

SEO Powered Content & PR Distribution. Get Amplified Today.
Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
Source: https://www.law360.com/ip/articles/1554861?utm_source=rss&utm_medium=rss&utm_campaign=section

Generative Data Intelligence

Fed. Circ. Won’t Rethink Axed Stanford Kidney Test Patents

ETS consultation: ‘signal versus noise’ suggests eventual price rise

Interview with content manager Ha Jeong-min | Innovative site operation that focuses on trends

Latest Intelligence

Hey Scarlett Johansson, OpenAI forgot to delete Sky from ChatGPT’s mobile app

Data Owner vs. Data Steward: What’s the Difference? – DATAVERSITY

Technology Audit Processes Are Broken, but Attention and Automation Can Fix Them – DATAVERSITY

Unlocking Connectivity: The Satellite Industry’s Approach to Achieving Interoperability with Telco

Tesla Board Pushes Backdoor Hype For Musk’s Exorbitant Pay Package – CleanTechnica

Bitcoin Value Skyrockets Beyond $70,000 Amidst Soaring Daily Trading Activity – CryptoInfoNet